BWM
GILD icon

Braeburn Wealth Management’s Gilead Sciences GILD Stock Holding History

Braeburn Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,810
Closed -$810K – 105
2026
Q1 		$810K Sell
5,810
-8,107
-58% -$1.14M 0.46% 41
2025
Q4 		$1.71M Buy
+13,917
New +$1.69M 0.87% 24

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Braeburn Wealth Management's GILD Position: Q2 2026 in Review

Braeburn Wealth Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 5,810 shares — an estimated $810K sold.

Braeburn Wealth Management first reported a position in GILD in Q4 2025 and held it in 2 quarters. The position peaked at $1.71M in Q4 2025. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Braeburn Wealth Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Braeburn Wealth Management sold 5,810 Gilead Sciences shares in Q2 2026, an estimated $810K.
  • Braeburn Wealth Management first reported a position in Gilead Sciences in Q4 2025 and held it in 2 quarters.
  • Braeburn Wealth Management's Gilead Sciences position peaked at $1.71M in Q4 2025.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Braeburn Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.